About Us


BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.

Note: To find a complete list of Publications, please see listing here.


Found 151 results
A. Rashidi, DiPersio, J. F., Sandmaier, B. M., Colditz, G. A., and Weisdorf, D. J., Steroids Versus Steroids Plus Additional Agent in Frontline Treatment of Acute Graft-versus-Host Disease: A Systematic Review and Meta-Analysis of Randomized Trials., Biol Blood Marrow Transplant, vol. 22, no. 6, pp. 1133-1137, 2016.
H. S. L. Jim, Sutton, S. K., Small, B. J., Jacobsen, P. B., Wood, W. A., Knight, J. M., Majhail, N. S., Syrjala, K. L., and Lee, S. J., Trajectories of Quality of Life after Hematopoietic Cell Transplantation: Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network 0902 Data., Biol Blood Marrow Transplant, vol. 22, no. 11, pp. 2077-2083, 2016.
S. Shenoy, Eapen, M., Panepinto, J. A., Logan, B. R., Wu, J., Abraham, A., Brochstein, J., Chaudhury, S., Godder, K., Haight, A. E., Kasow, K. A., Leung, K., Andreansky, M., Bhatia, M., Dalal, J., Haines, H., Jaroscak, J., Lazarus, H. M., Levine, J. E., Krishnamurti, L., Margolis, D., Megason, G. C., Yu, L. C., Pulsipher, M. A., Gersten, I., DiFronzo, N., Horowitz, M. M., Walters, M. C., and Kamani, N., A trial of unrelated donor marrow transplantation for children with severe sickle cell disease., Blood, vol. 128, no. 21, pp. 2561-2567, 2016.
F. Ravandi, Othus, M., O'Brien, S. M., Forman, S. J., Ha, C. S., Wong, J. Y. C., Tallman, M. S., Paietta, E., Racevskis, J., Uy, G. L., Horowitz, M., Takebe, N., Little, R., Borate, U., Kebriaei, P., Kingsbury, L., Kantarjian, H. M., Radich, J. P., Erba, H. P., and Appelbaum, F. R., US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL., Blood Adv, vol. 1, no. 3, pp. 250-259, 2016.
W. W. Hope, Walsh, T. J., Goodwin, J., Peloquin, C. A., Howard, A., Kurtzberg, J., Mendizabal, A., Confer, D. L., Bulitta, J., Baden, L. R., Neely, M. N., and Wingard, J. R., Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial., J Antimicrob Chemother, vol. 71, no. 8, pp. 2234-40, 2016.
F. R. Appelbaum, Anasetti, C., Antin, J. H., Atkins, H., Davies, S., Devine, S., Giralt, S., Heslop, H., Laport, G., Lee, S. J., Logan, B., Pasquini, M., Pulsipher, M., Stadtmauer, E., Wingard, J. R., and Horowitz, M. M., Blood and marrow transplant clinical trials network state of the Science Symposium 2014., Biol Blood Marrow Transplant, vol. 21, no. 2, pp. 202-24, 2015.
S. G. Holtan, Verneris, M. R., Schultz, K. R., Newell, L. F., Meyers, G., He, F., DeFor, T. E., Vercellotti, G. M., Slungaard, A., MacMillan, M. L., Cooley, S. A., Blazar, B. R., Panoskaltsis-Mortari, A., and Weisdorf, D. J., Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802., Biol Blood Marrow Transplant, vol. 21, no. 6, pp. 1029-36, 2015.
N. Khera, Majhail, N. S., Brazauskas, R., Wang, Z., He, N., Aljurf, M. D., Akpek, G., Atsuta, Y., Beattie, S., Bredeson, C. N., Burns, L. J., Dalal, J. D., Freytes, C. O., Gupta, V., Inamoto, Y., Lazarus, H. M., LeMaistre, C. F., Steinberg, A., Szwajcer, D., Wingard, J. R., Wirk, B., Wood, W. A., Joffe, S., Hahn, T. E., Loberiza, F. R., Anasetti, C., Horowitz, M. M., and Lee, S. J., Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial., Biol Blood Marrow Transplant, vol. 21, no. 10, pp. 1815-22, 2015.
P. Anderlini, Wu, J., Gersten, I., Ewell, M., Tolar, J., Antin, J. H., Adams, R., Arai, S., Eames, G., Horwitz, M. E., McCarty, J., Nakamura, R., Pulsipher, M. A., Rowley, S., Leifer, E., Carter, S. L., DiFronzo, N. L., Horowitz, M. M., Confer, D., H Deeg, J., and Eapen, M., Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study., Lancet Haematol, vol. 2, no. 9, pp. e367-75, 2015.
S. M. Devine, Owzar, K., Blum, W., Mulkey, F., Stone, R. M., Hsu, J. W., Champlin, R. E., Bin Chen, Y. -, Vij, R., Slack, J., Soiffer, R. J., Larson, R. A., Shea, T. C., Hars, V., Sibley, A. B., Giralt, S., Carter, S., Horowitz, M. M., Linker, C., and Alyea, E. P., Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncolo, J Clin Oncol, vol. 33, no. 35, pp. 4167-75, 2015.
J. E. Levine, Braun, T. M., Harris, A. C., Holler, E., Taylor, A., Miller, H., Magenau, J., Weisdorf, D. J., Ho, V. T., Bolaños-Meade, J., Alousi, A. M., and Ferrara, J. L. M., A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study., Lancet Haematol, vol. 2, no. 1, pp. e21-9, 2015.
A. C Howard, Fernandez-Vina, M. A., Appelbaum, F. R., Confer, D. L., Devine, S. M., Horowitz, M. M., Mendizabal, A., Laport, G. G., Pasquini, M. C., and Spellman, S. R., Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)., Biol Blood Marrow Transplant, vol. 21, no. 1, pp. 4-7, 2015.
M. L. MacMillan, Robin, M., Harris, A. C., DeFor, T. E., Martin, P. J., Alousi, A., Ho, V. T., Bolaños-Meade, J., Ferrara, J. L. M., Jones, R., Arora, M., Blazar, B. R., Holtan, S. G., Jacobsohn, D., Pasquini, M., Socie, G., Antin, J. H., Levine, J. E., and Weisdorf, D. J., A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality., Biol Blood Marrow Transplant, vol. 21, no. 4, pp. 761-7, 2015.
J. L. M. Ferrara, Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007., Biol Blood Marrow Transplant, vol. 20, no. 2, pp. 149-53, 2014.
J. A. Roth, Bensink, M. E., O'Donnell, P. V., Fuchs, E. J., Eapen, M., and Ramsey, S. D., Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer., J Comp Eff Res, vol. 3, no. 2, pp. 135-44, 2014.
P. B. Jacobsen, Le-Rademacher, J., Jim, H., Syrjala, K., Wingard, J. R., Logan, B., Wu, J., Majhail, N. S., Wood, W., J Rizzo, D., Geller, N. L., Kitko, C., Faber, E., Abidi, M. H., Slater, S., Horowitz, M. M., and Lee, S. J., Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902., Biol Blood Marrow Transplant, vol. 20, no. 10, pp. 1530-6, 2014.
G. E. Switzer, Bruce, J. G., Harrington, D., Haagenson, M., Drexler, R., Foley, A., Confer, D., Bishop, M., Anderlini, P., Rowley, S., Leitman, S. F., Anasetti, C., and Wingard, J. R., Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201., Biol Blood Marrow Transplant, vol. 20, no. 1, pp. 118-27, 2014.
E. K. Waller, Logan, B. R., Harris, W. A. C., Devine, S. M., Porter, D. L., Mineishi, S., McCarty, J. M., Gonzalez, C. E., Spitzer, T. R., Krijanovski, O. I., Linenberger, M. L., Woolfrey, A., Howard, A., Wu, J., Confer, D. L., and Anasetti, C., Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201., J Clin Oncol, vol. 32, no. 22, pp. 2365-72, 2014.
M. Eapen, O'Donnell, P., Brunstein, C. G., Wu, J., Barowski, K., Mendizabal, A., and Fuchs, E. J., Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies., Biol Blood Marrow Transplant, vol. 20, no. 10, pp. 1485-92, 2014.
W. Saber, Le Rademacher, J., Sekeres, M., Logan, B., Lewis, M., Mendizabal, A., Leifer, E., Appelbaum, F. R., Horowitz, M. M., Nakamura, R., and Cutler, C. S., Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and M, Biol Blood Marrow Transplant, vol. 20, no. 10, pp. 1566-72, 2014.
J. E. Wagner, Eapen, M., Carter, S., Wang, Y., Schultz, K. R., Wall, D. A., Bunin, N., Delaney, C., Haut, P., Margolis, D., Peres, E., Verneris, M. R., Walters, M., Horowitz, M. M., and Kurtzberg, J., One-unit versus two-unit cord-blood transplantation for hematologic cancers., N Engl J Med, vol. 371, no. 18, pp. 1685-94, 2014.
J. Bolaños-Meade, Logan, B. R., Alousi, A. M., Antin, J. H., Barowski, K., Carter, S. L., Goldstein, S. C., Hexner, E. O., Horowitz, M. M., Lee, S. J., Levine, J. E., MacMillan, M. L., Martin, P. J., Mendizabal, A. M., Nakamura, R., Pasquini, M. C., Weisdorf, D. J., Westervelt, P., and Ho, V. T., Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802., Blood, vol. 124, no. 22, pp. 3221-7; quiz 3335, 2014.
G. A. Yanik, Horowitz, M. M., Weisdorf, D. J., Logan, B. R., Ho, V. T., Soiffer, R. J., Carter, S. L., Wu, J., Wingard, J. R., DiFronzo, N. L., Ferrara, J. L., Giralt, S., Madtes, D. K., Drexler, R., White, E. S., and Cooke, K. R., Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials ne, Biol Blood Marrow Transplant, vol. 20, no. 6, pp. 858-64, 2014.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. - H., Carter, S. L., Horowitz, M. M., and Antin, J. H., Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT., Blood, vol. 124, no. 8, pp. 1372-7, 2014.
E. Atallah, Bylow, K., Troy, J., and Saber, W., Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT)., Curr Hematol Malig Rep, vol. 9, no. 1, pp. 57-65, 2014.